PMDA drug package insert
シクロスポリンカプセル10mg「BMD」
PMDA Prescription drug · 株式会社ビオメディクス · package insert Jun 17, 2026
Key facts
| Brand names | シクロスポリンカプセル10mg「BMD」, シクロスポリンカプセル25mg「BMD」, シクロスポリンカプセル50mg「BMD」 |
|---|---|
| Nonproprietary names | シクロスポリン |
| Companies | 製造販売元／株式会社ビオメディクス, 販売元／日本ジェネリック株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 免疫抑制剤 |
| Therapeutic category codes | 873999 |
| YJ codes | 3999004M3080, 3999004M4087, 3999004M5083 |
| Approval numbers | 22300AMX00104000, 21800AMZ10135000, 21800AMZ10136000 |
| Package insert edition | 第6版 |
| Package insert date | Jun 17, 2026 |
| PMDA document key | 650208_3999004M3080_6 |
| PMDA company code | 650208 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: